Cost-effectiveness of HIV Prevention Interventions in Sub-Saharan Africa: A Systematic Review
Authors:
Open Access
- 1 April 2019
- journal article
- review article
- Published by Elsevier in eClinicalMedicine
- Vol. 10, 10-31
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (K01 MH107320)
- Emory University
- Emory Center for AIDS Research (P30AI050409)
This publication has 74 references indexed in Scilit:
- Cost-effectiveness of tenofovir gel in urban South Africa: model projections of HIV impact and threshold product pricesBMC Infectious Diseases, 2014
- Reach and Cost-Effectiveness of the PrePex Device for Safe Male Circumcision in UgandaPLOS ONE, 2013
- Voluntary Medical Male Circumcision: Modeling the Impact and Cost of Expanding Male Circumcision for HIV Prevention in Eastern and Southern AfricaPLOS Medicine, 2011
- Optimal Uses of Antiretrovirals for Prevention in HIV-1 Serodiscordant Heterosexual Couples in South Africa: A Modelling StudyPLOS Medicine, 2011
- Assessing effectiveness and cost-effectiveness of concurrency reduction for HIV preventionInternational Journal of STD & AIDS, 2011
- Epidemiological Impact of Tenofovir Gel on the HIV Epidemic in South AfricaJAIDS Journal of Acquired Immune Deficiency Syndromes, 2011
- Preventing Mother to Child Transmission of HIV With Highly Active Antiretroviral Treatment in Tanzania-a Prospective Cost-Effectiveness StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2010
- Male Circumcision at Different Ages in Rwanda: A Cost-Effectiveness StudyPLOS Medicine, 2010
- HIV prevention cost-effectiveness: a systematic reviewBMC Public Health, 2009
- Depression and body mass index, a u-shaped associationBMC Public Health, 2009